SLAMF8 Participates in Acute Renal Transplant Rejection via TLR4 Pathway on Pro-Inflammatory Macrophages

被引:19
作者
Teng, Lisha [1 ,2 ,3 ,4 ]
Shen, Lingling [1 ,2 ,3 ,4 ]
Zhao, Wenjun [1 ,2 ,3 ,4 ]
Wang, Cuili [1 ,2 ,3 ,4 ]
Feng, Shi [1 ,2 ,3 ,4 ]
Wang, Yucheng [1 ,2 ,3 ,4 ]
Bi, Yan [1 ,2 ,3 ,4 ]
Rong, Song [5 ]
Shushakova, Nelli [5 ]
Haller, Hermann [5 ]
Chen, Jianghua [1 ,2 ,3 ,4 ]
Jiang, Hong [1 ,2 ,3 ,4 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Kidney Dis Ctr, Hangzhou, Peoples R China
[2] Key Lab Nephropathy, Hangzhou, Peoples R China
[3] Zhejiang Univ, Inst Nephropathy, Hangzhou, Peoples R China
[4] Zhejiang Clin Res Ctr Kidney & Urinary Syst Dis, Hangzhou, Peoples R China
[5] Hannover Med Sch, Dept Nephrol, Hannover, Germany
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
acute rejection; renal transplantation; weighted gene co-expression network analysis (WGCNA); hub gene; SLAMF8; gene set enrichment analysis; TERM GRAFT-SURVIVAL; CELL-MEDIATED REJECTION; KIDNEY-TRANSPLANTATION; POLARIZATION; DOCK2; DEFICIENCY; REGULATOR; NETWORKS; DISEASE;
D O I
10.3389/fimmu.2022.846695
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundAcute rejection (AR) in kidney transplantation is an established risk factor that reduces the survival rate of allografts. Despite standard immunosuppression, molecules with regulatory control in the immune pathway of AR can be used as important targets for therapeutic operations to prevent rejection. MethodsWe downloaded the microarray data of 15 AR patients and 37 non-acute rejection (NAR) patients from Gene Expression Omnibus (GEO). Gene network was constructed, and genes were classified into different modules using weighted gene co-expression network analysis (WGCNA). Kyoto Encyclopedia of Genes and Genomes (KEGG) and Cytoscape were applied for the hub genes in the most related module to AR. Different cell types were explored by xCell online database and single-cell RNA sequencing. We also validated the SLAMF8 and TLR4 levels in Raw264.7 and human kidney tissues of TCMR. ResultsA total of 1,561 differentially expressed genes were filtered. WGCNA was constructed, and genes were classified into 12 modules. Among them, the green module was most closely associated with AR. These genes were significantly enriched in 20 pathway terms, such as cytokine-cytokine receptor interaction, chemokine signaling pathway, and other important regulatory processes. Intersection with GS > 0.4, MM > 0.9, the top 10 MCC values and DEGs in the green module, and six hub genes (DOCK2, NCKAP1L, IL2RG, SLAMF8, CD180, and PTPRE) were identified. Their expression levels were all confirmed to be significantly elevated in AR patients in GEO, Nephroseq, and quantitative real-time PCR (qRT-PCR). Single-cell RNA sequencing showed that AR patient had a higher percentage of native T, CD1C+_B DC, NKT, NK, and monocytes in peripheral blood mononuclear cells (PBMCs). Xcell enrichment scores of 20 cell types were significantly different (p<0.01), mostly immune cells, such as B cells, CD4+ Tem, CD8+ T cells, CD8+ Tcm, macrophages, M1, and monocytes. GSEA suggests that highly expressed six hub genes are correlated with allograft rejection, interferon gamma response, interferon alpha response, and inflammatory response. In addition, SLAMF8 is highly expressed in human kidney tissues of TCMR and in M1 phenotype macrophages of Raw264.7 cell line WGCNA accompanied by high expression of TLR4. ConclusionThis study demonstrates six hub genes and functionally enriched pathways related to AR. SLAMF8 is involved in the M1 macrophages via TLR4, which contributed to AR process.
引用
收藏
页数:15
相关论文
共 50 条
[1]   Kidney transplantation as primary therapy for end-stage renal disease:: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) conference [J].
Abecassis, Michael ;
Bartlett, Stephen T. ;
Collins, Allan J. ;
Davis, Connie L. ;
Delmonico, Francis L. ;
Friedewald, John J. ;
Hays, Rebecca ;
Howard, Andrew ;
Jones, Edward ;
Leichtman, Alan B. ;
Merion, Robert M. ;
Metzger, Robert A. ;
Pradel, Francoise ;
Schweitzer, Eugene J. ;
Velez, Ruben L. ;
Gaston, Robert S. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (02) :471-480
[2]   Toll-like receptor signaling pathways [J].
Barton, GM ;
Medzhitov, R .
SCIENCE, 2003, 300 (5625) :1524-1525
[3]   Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation [J].
Bhargava, Pavan ;
Fitzgerald, Kathryn C. ;
Calabresi, Peter A. ;
Mowry, Ellen M. .
JCI INSIGHT, 2017, 2 (19)
[4]   Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth [J].
Cao, Meng ;
Yan, Huaijiang ;
Han, Xuan ;
Weng, Ling ;
Wei, Qin ;
Sun, Xiaoyan ;
Lu, Wuguang ;
Wei, Qingyun ;
Ye, Juan ;
Cai, Xueting ;
Hu, Chunping ;
Yin, Xiaoyang ;
Cao, Peng .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
[5]   Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015 [J].
Coemans, Maarten ;
Suesal, Caner ;
Doehler, Bernd ;
Anglicheau, Dany ;
Giral, Magali ;
Bestard, Oriol ;
Legendre, Christophe ;
Emonds, Marie-Paule ;
Kuypers, Dirk ;
Molenberghs, Geert ;
Verbeke, Geert ;
Naesens, Maarten .
KIDNEY INTERNATIONAL, 2018, 94 (05) :964-973
[6]   Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection [J].
Dangi, Anil ;
Natesh, Naveen R. ;
Husain, Irma ;
Ji, Zhicheng ;
Barisoni, Laura ;
Kwun, Jean ;
Shen, Xiling ;
Thorp, Edward B. ;
Luo, Xunrong .
JCI INSIGHT, 2020, 5 (20)
[7]   Intragraft Toll-like receptor profiling in acute renal allograft rejection [J].
Dessing, Mark C. ;
Bemelman, Frederike J. ;
Claessen, Nike ;
ten Berge, Ineke J. M. ;
Florquin, Sandrine ;
Leemans, Jaklien C. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (12) :4087-4092
[8]   Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections [J].
Dobbs, K. ;
Conde, C. Dominguez ;
Zhang, S. -Y. ;
Parolini, S. ;
Audry, M. ;
Chou, J. ;
Haapaniemi, E. ;
Keles, S. ;
Bilic, I. ;
Okada, S. ;
Massaad, M. J. ;
Rounioja, S. ;
Alwahadneh, A. M. ;
Serwas, N. K. ;
Capuder, K. ;
Ciftci, E. ;
Felgentreff, K. ;
Ohsumi, T. K. ;
Pedergnana, V. ;
Boisson, B. ;
Haskologlu, S. ;
Ensari, A. ;
Schuster, M. ;
Moretta, A. ;
Itan, Y. ;
Patrizi, O. ;
Rozenberg, F. ;
Lebon, P. ;
Saarela, J. ;
Knip, M. ;
Petrovski, S. ;
Goldstein, D. B. ;
Parrott, R. E. ;
Savas, B. ;
Schambach, A. ;
Tabellini, G. ;
Bock, C. ;
Chatila, T. A. ;
Comeau, A. M. ;
Geha, R. S. ;
Abel, L. ;
Buckley, R. H. ;
Ikinciogullari, A. ;
Al-Herz, W. ;
Helminen, M. ;
Dogu, F. ;
Casanova, J. -L. ;
Boztug, K. ;
Notarangelo, L. D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2409-2422
[9]   Relevance of Toll-like receptor-4 polymorphisms in renal transplantation [J].
Ducloux, D ;
Deschamps, M ;
Yannaraki, M ;
Ferrand, C ;
Bamoulid, J ;
Saas, P ;
Kazory, A ;
Chalopin, JM ;
Tiberghien, P .
KIDNEY INTERNATIONAL, 2005, 67 (06) :2454-2461
[10]   CYC1, SDHA, UQCRC1, UQCRQ, and SDHB might be important biomarkers in kidney transplant rejection [J].
Fan, Pengfei ;
Zhang, Weiye ;
Liu, Yi .
CLINICA CHIMICA ACTA, 2020, 507 :132-138